About this trial
The prone position leads to a more homogeneous distribution of ventilation by inflation of collapsed alveoli and reduction in alveolar hyperinflation. By employing EIT, the study can obtain a thorough comprehension of the ongoing alterations in regional ventilation before and after adopting the prone position. It is also anticipated that there is an impact on inflammation biomarkers before and after the prone position. This assessment aids in determining the ideal duration for prone position therapy, encompassing the necessary hours and days in the prone position.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Acute respiratory distress syndrome
Age > 18
Serial arterial blood gas data:PaO2/FiO2 <150. The mechanical ventilator setting:FiO2>0.6, PEEP>5 cmH2O
Disqualifiers
Implantable electronic devices (e.g., pacemakers)
Body mass index > 30
Major thoracic and abdominal surgery
Patients with unstable spine and pelvis conditions
Trial population
This study focuses on patients with severe acute respiratory distress syndrome undergoing prone position therapy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Electrical Impedance Tomography
DeviceIt utilizes electrical impedance tomography to analyze a series of physiological changes in the lungs following treatment
Treatment groups
Trial outcomes
Primary outcomes
Prone response
Responder is defined as an increase in PaO2 by 20 mmHg or an increase in PaO2/FiO2 by 20% one hour after receiving prone position therapy
Secondary outcomes
28-day mortality
The mortality status on the 28th day
Sponsors and contacts
Click on the lead sponsor to view all of their trials.